Sigma-Aldrich Asks Court to Reject Open Biosystems' Request to Dismiss IP Suit

According to Sigma-Aldrich, Open Biosystems’ contention that the life sciences giant did not have “all substantial rights” to the patents in question, and therefore was not in a position to file a patent-infringement suit, is based on “a fundamental error of law.”

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.